Gilead Withdraws Request for Special Orphan Status on Experimental Virus Treatment

Bowing to criticism that it was exploiting the coronavirus pandemic, the drugmaker Gilead said on Wednesday that it would no longer seek orphan-drug status for remdesivir, an experimental drug that is being tested as a possible treatment. The Food and Drug Administration had only granted the special designation on Monday — which gives drug companies […]

Read More